Consensus Alcon Inc.

Equities

ALC

CH0432492467

Real-time Estimate Cboe Europe 10:09:09 2024-05-16 am EDT 5-day change 1st Jan Change
81.17 CHF +0.56% Intraday chart for Alcon Inc. +10.05% +23.40%

Evolution of the average Target Price on Alcon Inc.

Price target over the last 5 years

History of analyst recommendation changes

522397a317d0.y7gCcxLET9apKsWzXtS7lmXpNHLQ1bMmSse8qI0huf4.it5NIlqdIO7sTLH8GeDZwCHeDCXhuNAWMonV7rptgLS_gEsHYvcEvPFYkA~0e4b7a431d8083de89e1e49fba3a4eac
Stifel Adjusts Price Target on Alcon to $100 From $95, Maintains Buy Rating MT
Oppenheimer Upgrades Alcon to Outperform From Perform, $103 Price Target MT
Baird Adjusts Price Target on Alcon to $104 From $95, Maintains Outperform Rating MT
Needham Adjusts Price Target on Alcon to $101 From $98, Keeps Buy Rating MT
ALCON : Markets rejoice at the Q1 beat; guidance upgraded Alphavalue
ALCON : Alcon should be viewed with a slightly longer-term lens Alphavalue
UBS Boosts Alcon PT, Affirms Buy Rating MT
ALCON : price target raised by UBS CF
Argus Raises Alcon's Price Target to $100 From $90, Maintains Buy Rating MT
Mizuho Securities Raises Price Target on Alcon to $100 From $95, Maintains Buy Rating MT
Needham Raises Alcon's PT to $98 From $86 After 'Solid' Q4 2023 Results, Above-Consensus 2024 Guidance; Keeps Buy Rating MT
ALCON : Despite the slight Q4 miss, the markets cheered the 2024 guidance Alphavalue
KeyBanc Initiates Alcon at Overweight Rating With $87 Price Target MT
Bernstein Initiates Alcon at Outperform With $94.40 Price Target MT
Argus Cuts Price Target on Alcon to $90 From $95, Maintains Buy Rating MT
Morgan Stanley Downgrades Alcon to Underweight From Equalweight, Cuts Price Target to $65 From $85 MT
UBS Reduces Alcon PT, Affirms Buy Rating MT
ALCON : UBS lowers price target CF
Jefferies Adjusts Price Target on Alcon to $88 From $94, Maintains Buy Rating MT
ALCON : Healthy Q3; markets disappointed with the narrowed guidance Alphavalue
Argus Adjusts Alcon's Price Target to $95 From $90, Keeps Buy Rating MT
Berenberg Lifts Price Target on Alcon, Maintains Buy Recommendation MT
BNP Paribas Exane Adjusts Price Target on Alcon to $103.72 From $100.19, Maintains Outperform Rating MT
Nephron Research Adjusts Price Target on Alcon to $97 From $95, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Alcon to $89 From $80, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
89.37 USD
Average target price
93.64 USD
Spread / Average Target
+4.78%
High Price Target
101.3 USD
Spread / Highest target
+13.29%
Low Price Target
68.41 USD
Spread / Lowest Target
-23.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alcon Inc.

Stifel Nicolaus
Oppenheimer
Baird
Needham & Co.
alphavalue Abhishek Raval
UBS
Argus
Mizuho Securities
KeyBanc Capital Markets
Bernstein
Morgan Stanley
Jefferies & Co.
Berenberg Bank
Nephron Research
BNP Paribas Exane
Societe Generale
Wells Fargo Securities
JPMorgan Chase
Citigroup
BTIG
Credit Suisse
BNP Paribas
DA Davidson
Stephens Inc.
Goldman Sachs
Exane BNP
Kepler Capital Markets
SVB Leerink
Davy
Octagon Capital
JPMORGAN James Gordon
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW